WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020

Feb 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-02-18

Reporting Person: Birkett Bernard (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-18	Stock Options (Right to Buy)	$173.22	A	12752.00	Acquired	2030-02-18	Common Stock (12752.00)	Direct

Footnotes

F1: This award vests in four equal annual installments beginning on February 18, 2021.